Inflation still slowing, CPI to show, but some warning signs might flash
Core prices are seen as a better signal of future inflation. The cost of groceries and gasoline can show big swings from time to time and exaggerate the overall level of prices. The biggest source of ...
Don’t Make These Mistakes With Generative AI in Your Practice
If used properly, generative AI can help advisors take care of administrative tasks and allow them to spend more time on the ...
U.S., and intriguingly, Australia, have the most expensive stocks by one measure
What Muir found when looking at the Z scores of forward price-to-equity ratios around the world, was that it's almost all U.S. indexes on top. The one exception, interestingly, came from Australia.
Why a CPI surprise could trip up the Fed's rate-cutting plans
Traders were pricing in a roughly 88% chance of a 25-basis-point rate cut at the Fed's next decision day on Nov. 7, with the odds of no change hovering near 11%, according to the CME's FedWatch tool ...
Biogen's stock bounces after FDA boost on kidney-transplant rejection treatment
Biogen's stock has had a rough time over the past few months. In late July, not only did European regulators reject Biogen's treatment for Alzheimer's disease, the company and partner Sage ...
Biogen Gets FDA Breakthrough Designation for Kidney-Transplant Drug
Biogen said it won Food and Drug Administration breakthrough-therapy designation for its proposed treatment for a major cause of kidney-transplant failure.
Morningstar2 小时
Oil prices extend retreat after industry data shows rise in U.S. crude inventories
Oil futures were lower Wednesday morning ahead of official data on U.S. inventories, extending a sharp pullback seen the previous session on prospects for a cease-fire between Israel and Hezbollah ...
Kymera Therapeutics' Application for KT-621 Gets FDA Clearance
Kymera Therapeutics received clearance from the Food and Drug Administration for its investigational new drug application of KT-621. The clinical stage biopharmaceutical company said it expects to ...
How phones and computers are bombarding our brains and creating a FOMO epidemic
But here's the catch: The pleasure we derive from screens is shallow and fleeting, unlike the lasting satisfaction that comes from face-to-face interactions. Steady screen interruptions increase ...
Morningstar2 小时
The U.S. fertility rate is falling. Is there anything we can do?
The decline in the fertility rate is a significant development, not just in the U.S. but around the world. Some laud the trend as an example of women's ability to control their destiny; others decry ...
Wall Street's most bearish firm on stocks says there's a chance of an upswing
For investors looking to play the broadening cyclical recovery ahead of the year-end holiday season, they like what they call U.S. consumer laggards with brand value, which include Tesla (TSLA), ...
Ocugen Says FDA Lifts Clinical Hold on Diabetic Macular Edema Drug
Ocugen said the Food and Drug Administration lifted a clinical hold on its OCU200 investigational treatment for diabetic macular edema, paving the way for Phase 1 trials.